FindTrial
Sign In

CoV-PREMOC Sars-CoV-2 Infection (Covid-19) During Pregnancy: Effects on Mother and Child

CoV-PREMOC Sars-CoV-2 Infection (Covid-19) During Pregnancy: Effects on Mother and Child - CoV-PREMOC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00023447
Enrollment
30
Registered
2020-11-03
Start date
2020-11-13
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z03.8 Z29.0 Z34 Z35.8

Interventions

Group 1: During pregnancy and during childbirth, samples should be taken from mother and child, especially samples of body fluids (saliva, blood, umbilical cord blood, urine, stool, amniotic fluid), a

Sponsors

Klinik und Poliklinik für Radiologie Klinikum der Universität München Campus Großhadern
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. infection with Sars-CoV-2 during pregnancy, confirmed by smear or blood test 2. all weeks of pregnancy possible 3. infection can be acute or already expired

Exclusion criteria

Exclusion criteria: Contraindications against native MRI (no contrast) --> claustrophobia -->Metallic implants that are not suitable for MRI

Design outcomes

Primary

MeasureTime frame
Morphological and/or spectroscopic pathologies of the placenta in MRI imaging.—

Secondary

MeasureTime frame
Morphological and/or spectroscopic pathologies of the fetus in MRI imaging—

Countries

Germany

Contacts

Public ContactGloria Biechele

Klinik und Poliklinik für RadiologieKlinikum der Universität München, LMU

Gloria.Biechele@med.uni-muenchen.de089/4400 73620

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026